Our Platforms

We are developing and advancing novel platform technologies to usher in a new era of immunotherapy

At BioNTech, we apply our deep expertise in immunology, drug discovery and fundamental research to develop and advance a toolbox of groundbreaking technologies spanning four drug classes to provide novel treatments and vaccines for people around the world to improve global health.

With a deep understanding of the underlying science, and based on nearly two decades of groundbreaking research, mRNA therapeutics are our most advanced assets. In addition, we use the specific properties of cell therapies, antibodies and small molecules, or even synergistic combinations of those different drug classes, to address the treatment challenges for a range of cancer and infectious disease indications. 

Broadening the treatment universe

We are continuously building out our platforms and approaches aiming to harness the full power of the immune system and provide better medicines for patients worldwide.

We are continuously building out our platforms and approaches aiming to harness the full power of the immune system and provide better medicines for patients worldwide.

Learn more about our platforms here

mRNA-based
platforms

antibody-based
platforms

cell therapy-based platforms

small molecule-based platforms

Learn more about our drug classes

Read also